What’s New in the CTN?

Updates from the NIDA National Drug Abuse Treatment Clinical Trials Network. Want to share some news about your protocol, node, publications or presentations, or other CTN-related work here and/or in the CTN Bulletin? Email us at ctnlib@uw.edu!

New in the Library (August – September 2026)

New in the Library

Here are the latest items added to the CTN Dissemination Library for August – September 2026 (this post will be updated as new items come in): Differences in benefits of office based opioid treatment: Secondary analyses across sub-groups in the PROUD randomized controlled implementation trial. Bradley KA, et al. Addiction 2026;121(3):629-642. (CTN-0074) A comparison of neuropsychological functioning between patients with opioid use disorder treated with extended-release naltrexone or buprenorphine-naloxone. Castillo F, et al. Journal of Addiction Medicine 2026 (in press). (CTN-0051) Patient attitudes toward substance use screening and discussion in…

News from the Greater Intermountain Node

Community Outreach for Recovery Month! This September, the Greater Intermountain Node team is celebrating Recovery Month by participating in community events across Utah. At First Step House, we connected with residents at an Ice Cream Social (left) and hosted booths at Utah Support Advocates for Recovery Awareness (USARA) Recovery Days events (right). We appreciate the chance to meet community members, share information, and support recovery-focused events throughout Utah! Shauna Filion joins ASAM PWLE Board! We are pleased to recognize Shauna Filion, Certified Lead Medical Assistant and GIN’s CIRCL representative, for…

CTN Annual Conference: March 15-17, 2027 (Bethesda, MD)

CTN Annual Scientific and Steering Committee Meeting March 15-17, 2027

We are pleased to announce that the CTN Annual Conference will be held March 15-17, 2027, at the National Institutes of Health (NIH) Campus in Bethesda, Maryland. Conference sessions will take place in the Natcher Building. To assist with conference planning, please take a moment to answer a few brief questions. Names and contact information are not being requested at this time. Your response will help the planning committee estimate aggregate participation and plan meeting logistics.  Please reserve these dates on your calendar. Additional information regarding registration, agenda, accommodations, and…

Protocol Update: CTN-0100 Completes Retention Phase

Protocol Update

The CTN-0100 team is proud to announce that the study completed data collection for its Retention Phase on September 2, 2026. Over the course of more than 5 years, our 18 incredible study sites enrolled, followed, and supported 1,140 participants in their recovery journey. More than 350 individuals worked on the Retention Phase, including site staff and investigators, colleagues at participating Nodes, and partners at Emmes and NIDA. We are grateful to everyone who contributed to this project, and thank you for your dedication to RDD and our study participants….

News from the Health Systems Node: Webinar on MOUD During Critical Illness (Oct. 1, 2026, 10am PT)

Node News: Health Systems Node

Join the Health Systems Node on October 1, 2026 (10am PT, 1pm ET) for their next virtual seminar featuring Ryan JJ Buckley, MD, MPH, MHS, Assistant Professor of Emergency Medicine and Medicine at Yale School of Medicine. In MOUD During Critical Illness: What We Know, What We’re Finding, and Where We’re Headed, Dr. Buckley will review current evidence on medications for opioid use disorder (MOUD) in intensive care settings, share preliminary findings from ongoing studies of ICU practice patterns, and discuss efforts to develop a protocolized ICU MOUD intervention for…

News from the New England Consortium Node & CTN-0100/RDD Update

Node News

At the CTN Quarterly Steering Committee Meeting on September 15, 2026, NECN member, Zoe Weinstein, MD, MS, co-led the final study report for the CTN-0098 along with study Co-Lead Investigator, Gavin Bart, MD, PhD, FACP, FASAM. Dr. Weinstein serves as the Site PI for the Boston University site for both CTN-0098A and CTN-0098B. NECN member, Richard Saitz, MD, MPH, FACP, DFASAM, study Co-Lead Investigator, passed away during the study, and he was acknowledged and honored as a leader and innovator of the study. CTN-0100/RDD study update This publication from the…

Western States Node Webinar: Therapeutic Potential of GLP-1 Receptor Agonists for Substance Use Disorders (Oct. 28, 11am PT)

herapeutic potential of GLP-1 receptor agonists for substance use disorders. Christian Hendershot, PhD, Keck School of Medicine, USC. October 28, 2026, 11am-12:30pm PT. 1.5 CME/CE available! Sponsored by the Northwest & Pacific Southwest ATTCs and the Western States Node of the NIDA Clinical Trials Network

Presenter: Christian Henderson, PhD, Keck School of Medicine, University of Southern California (read more about Dr. Henderson here) This presentation will summarize emerging evidence for the efficacy of GLP-1 receptor agonists for substance use disorders. Recent and ongoing Phase 2 clinical trials will be reviewed, and key clinical and implementation issues discussed. After this session, participants will be able to: 1.5 CE/CME available! Sponsored by the Northwest and Pacific Southwest ATTCs and the Western States Node of the NIDA Clinical Trials Network. About the presenter Christian Hendershot, PhD, is Professor…

Northeast Node Webinar: Using AI and Passive Data to Improve Digital Assessment and Treatment of Substance Use and Mental Health Disorders (Sept. 24, 2026, 12pm ET)

Node News Northeast

Join the Northeast Node for the next installment of their Science Series: Using AI and Passive Data to Improve Digital Assessment and Treatment of Substance Use and Mental Health Disorders (September 24, 2026, 12-1pm ET). Presented by Nicholas C. Jacobson, PhD. Dr. Jacobson, PhD, is an Associate Professor of Biomedical Data Science and Psychiatry at Dartmouth’s Geisel School of Medicine, where he directs the AI and Mental Health: Innovation in Technology Guided Healthcare (AIM HIGH) Laboratory. He has published over 130 peer-reviewed papers (H-index: 44), with a large portion focused on…

19th Annual Conference on the Science of Dissemination and Implementation in Health, December 13-16, 2026

19th Annual Conference on the Science of Dissemination and Implementation in Health, December 13-16, 2026

Join AcademyHealth, the National Institutes of Health, and over 1,000 individuals on the front lines of dissemination and implementation (D&I) science in public health, health care delivery, and health care policy at the 19th Annual Conference on the Science of Dissemination and Implementation in Health. This year’s theme is “Elevating the Science of Dissemination: Leveraging Tools to Improve Clinical, Community, and Public Health Practice,” and will investigate real-time integration of evidence-based interventions, understand their limitations, and identify unintended consequences in this rapidly shifting information landscape. Register by October 23, 2026,…

CTN-0133 EXPLORE Toolkit

EXPLORE Toolkit

CTN-0133, Exploring Health Beliefs for Community Engagement and Diversity in Clinical Trials (EXPLORE), aimed to develop a toolkit that would help improve inclusion and engagement of diverse populations in clinical research as a way to broaden the relevance and translation of research findings into practice. The EXPLORE toolkit is now available! The toolkit was developed through a multi-phase process that included systematic review of existing toolkits, domain development, platform design, individual interviews, and two rounds of theater testing with community health workers serving Hispanic communities in Southern New Mexico and…

News from the New York Node: CTN-0155 Launches Recruitment

Node News

CTN-0155 (Project BISTRO) has officially launched recruitment as of August 17, 2026! After many difficult but inspiring months of planning, training, and imagining a new approach to high-quality, person-centered, community-based opioid use disorder (OUD) treatment, we have launched Project BISTRO (Buprenorphine Implementation at SSPs to Reduce Overdoses). Eight (8) pioneering syringe services programs (SSPs) from across the United States are participating in the study and will build capacity to provide onsite buprenorphine treatment. Our team also includes researchers from CTN’s New York Node, Florida Node Alliance, and Appalachian Node, the…

News from the Greater Intermountain Node

AHSR 2026 The 2026 Addiction Health Services Research (AHSR) Conference will be held October 5-7, 2026, in Salt Lake City, Utah, home of the Greater Intermountain Node. The conference brings together addiction researchers, policymakers, and treatment providers to discuss challenges and opportunities related to equity, access, effectiveness, and implementation of addiction services. Early bird registration ends September 4, 2026. Register by that date to save $100. The conference hotel is likely to sell out, so early booking is recommended. Visit the AHSR 2026 website Save the Date for the CTN…

News from the Health Systems Node: Virtual Seminar September 3, 2026 (10am PT)

Node News: Health Systems Node

Join the CTN Health Systems Node for an upcoming virtual seminar: On Thursday, September 3, 2026 (10am PT, 1pm ET), Tessa Matson, PhD, MPH, Collaborative Scientist at Kaiser Permanente Washington Health Research Institute, will present findings from a CTN implementation trial on factors that distinguished clinics that successfully increased opioid use disorder treatment from those that did not. Connect via Microsoft Teams. Meeting ID: 250 658 877 216 6 | Passcode: B8jq2m9A.

New in the Library (July – August 2026)

New in the Library

Here are the latest items added to the CTN Dissemination Library for July – August 2026 (this post will be updated as new items come in): Insights from the development of an online toolkit to promote community engaged substance use research in the Southwest Borderlands Region. Gorvetzian A, et al. Journal of Clinical and Translational Science 2026;10(1):e139. (CTN-0133) Relationships between cannabis and cocaine use in a randomized trial of combined buprenorphine and naltrexone for DSM-IV cocaine dependence. Smith CL, et al. Addictive Behaviors 2026;183:108817. (CTN-0048) Leveraging partnerships to address substance…

Guam’s 7th Annual Behavioral Health & Addictions Virtual Conference, Sept. 23-24 2026

Guam Virtual Conference September 2026

The Greater Southern California Node and its Pacific Southwest Addiction Technology Transfer Center (PSATTC) partners would like to invite you to Guam’s 7th Annual Behavioral Behavioral Health & Addictions Virtual Conference. September 23-24, 2026 (3pm-9:30pm PT). This FREE two-day virtual conference held in recognition of National Recovery Month will feature 4 plenary presentations and 4 breakout sessions, offering 8 concurrent workshop tracks. Whether you are looking to strengthen your clinical practice, learn about emerging trends, or discover innovative approaches to providing care, this conference offers valuable education and practical strategies…

Development & Use of an Interactive Online Dashboard for CTN-0135

Protocol Update

CTN-0135, Buprenorphine Treatment Engagement and Induction Problems Among Individuals Using Fentanyl, examined whether fentanyl use and challenges starting buprenorphine/naloxone treatment vary across different regions in the U.S. The study also surveyed clinicians to better understand the challenges they face when starting buprenorphine treatment for patients using fentanyl and how they are adapting standard clinical protocols to better engage patients in care. Recognizing that scientific journals have low overall reach, particularly for non-scientific audiences, the study team created an interactive online data dashboard to make the data more accessible. After developing…

New in the Library (June – July 2026)

New in the Library

Here are the latest items added to the CTN Dissemination Library for June – July 2026 (this post will be updated as new items come in): Collaborative care intervention for risky opioid use among primary care patients: The STOP randomized clinical trial. McNeely J, et al. Addiction 2026 (in press). (Primary outcomes for CTN-0101) State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID-19 onset. Bórquez I, et al. Addiction 2025;120(6):1207-1222. (CTN-0112) Actions needed for pharmacy-dispensed methadone for opioid use…

1 2 … 16